| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2031 |
| Trial ID | NCT03768310 |
| Disease | Acute Lymphoblastic Leukemia | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19.CAR-multiVST |
| Phase | Phase1 |
| Recruitment status | Withdrawn |
| Title | CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA) |
| Year | 2018 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-36578 CARMA |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||